Completed Study to Evaluate Efficacy and Safety of Elamipretide in Subjects With Primary Mitochondrial Disease From Nuclear DNA Mutations (nPMD) NCT05162768 Conditions Chronic Disease, Cranial Nerve Diseases, Disease Attributes, +26 more Locations University of California, San Diego — San Diego, California, United States Rare Disease Research, LLC — Atlanta, Georgia, United States Massachusetts General Hospital — Boston, Massachusetts, United States Washington University School of Medicine — St Louis, Missouri, United States View all 32 locations View more locations Show fewer locations Loading locations... View Trial Details
